🚨 #ESMO26 GU Oncology — the studies I would keep closest on the radar
@OncoAlert
What stands out from the @OncoAlert GU selection is how clearly the field is moving toward perioperative intensification, biomarker-driven treatment, smarter sequencing, and new mechanisms of action.
🟠 #BladderCancer
VOLGA · KEYNOTE-B15 · ENERGIZE · KEYNOTE-866
🔵 #ProstateCancer
DASL-HiCaP · CAPItello-281 · PROTEUS
🟢 #KidneyCancer
LITESPARK-011 · LITESPARK-012 · ivonescimab · PE-PE · SWOG S2200 · XmAb819
🎯 Why this matters: these are not just isolated trial readouts. Together, they are redefining where we intensify, where we de-escalate, how we select patients, and how earlier disease settings are becoming increasingly systemic and biology-driven.
For me, the most important question across all three tumors is the same:
Who actually needs more treatment — and who can safely receive less?
That is where GU oncology is heading.
Proud to be part of this @OncoAlert faculty following the data closely at #ESMO26.
@DrChoueiri @tompowles1 @neerajaiims @PGrivasMDPhD @TiansterZhang @AndreaNecchi @DrRanaMcKay @DrYukselUrun @crisbergerot @nataliagandur
#OncoAlert #GUOncology #PrecisionOncology #CancerResearch
461 views · 10 likes · 4 reposts · 0 replies
Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial
https://esmocongress.esmo.orgVOLGA
https://esmocongress.esmo.org🚨 #ESMO26 GU Oncology — Top picks by OncoAlert 🎯 #BladderCancer : VOLGA, KEYNOTE-B15, ENERGIZE, KEYNOTE-866 #ProstateCancer: DASL-HiCaP, CAPItello-281, PROTEUS #KidneyCancer: LITESPARK-011 & -012, ivonescimab, PE-PE, SWOG S2200, XmAb819 Our Participating Faculty @DrChoueiri, @tompowles1, @apolo_andrea, @neerajaiims, @montypal, @Silke_Gillessen, @AOmlin, @brian_rini, @PGrivasMDPhD, @TiansterZhang, @amerseburger , @DrDanielHeng, @HHammersMD, @scocmem, @AndreaNecchi , @AmandaNizamMD, @drenriquegrande, @nataliagandur @AlbigesL, @cdanicas, @declangmurphy, @seanmmcbride, @shilpaonc, @DrRanaMcKay, @scserendipity1, @DrYukselUrun , @ravikanesvaran , @BraunMDPhD, @EfstathiouEleni, @mzugman , @crisbergerot, @ElisaAgostinett, @to_be_elizabeth, @MarioBalsaMD, @BRicciutiMD, @HHorinouchi, @UOzkerim, @p_ciracimd, @DrMirallas , @sonpavde , @Dr_Oncologista在 X 查看被引用的帖子
Source: Dra. María Natalia Gandur Quiroga · x.com